COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Provides Strategic Update on L-DOS47 Clinical Program

13/11/2018 - 23:05

RICHMOND HILL, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, provides a strategic [...]

Loop Industries Announces Change of CFO

13/11/2018 - 23:00

MONTREAL, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Loop Industries (Nasdaq:LOOP) (“Loop” or “Company”), a leading technology innovator in sustainable plastic resin and polyester fiber, today announced that CFO Frank Zitella [...]

Delcath Announces Third Quarter Fiscal 2018 Financial Results

13/11/2018 - 22:52

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]

Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update

13/11/2018 - 22:50

GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018. [...]

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results

13/11/2018 - 22:47

ANN ARBOR, Mich., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]

National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting

13/11/2018 - 22:37

Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded research, programs, [...]

Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update

13/11/2018 - 22:30

AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’ [...]

Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference

13/11/2018 - 22:30

MENLO PARK, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]

Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London

13/11/2018 - 22:29

Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention [...]

Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

13/11/2018 - 22:20

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (“ [...]

Homology Medicines Reports Third Quarter 2018 Financial Results

13/11/2018 - 22:16

On Track to Begin and Report Initial Clinical Data from PKU Gene Therapy Trial and to Start IND-Enabling Studies in PKU Gene Editing and MLD Gene Therapy Programs Next Year BEDFORD, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE [...]

Teligent, Inc. Announces Third Quarter 2018 Results

13/11/2018 - 22:15

BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter [...]

Teligent, Inc. Announces $120 Million Financing Commitment From Ares

13/11/2018 - 22:15

BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by Ares Management, L.P. (“ [...]

Resonant Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update

13/11/2018 - 22:05

GOLETA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]

electroCore, Inc. Announces Third Quarter Financial Results

13/11/2018 - 22:05

BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three months and nine [...]

Merit Medical Closes Cianna Medical, Inc. Deal

13/11/2018 - 22:05

SOUTH JORDAN, Utah, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Evoke Pharma Reports Third Quarter 2018 Results

13/11/2018 - 22:05

April 1, 2019 PDUFA date for Gimoti™ NDA Cash runway extended through June 2019 SOLANA BEACH, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on [...]

ImmuCell Announces Financial Results for Third Quarter of 2018

13/11/2018 - 22:05

PORTLAND, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Marrone Bio Innovations, Inc. Reports Third Quarter 2018 Financial Results

13/11/2018 - 22:05

Year-Over-Year Revenues Increase 29% to Third Quarter Record of $5.4 Million; Gross Margins Expand to Record 48.3%; Operating Expenses Decrease by 19% to $6.8 Million DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]